Clients receiving a 2.4 mg dose of semaglutide weekly experienced an average weight reduction of approximately 14.9% over 68 weeks, significantly surpassing the results of those on placebo
This value gets split among manufacturers, third-party payers like Medicare, and patients, depending on how much of the social value accrues to each
To address this, some companies use stabilized forms like Na-R-ALA (sodium-R-alpha-lipoate), which binds R-ALA to sodium to help resist degradation
[13] TrumpRx Program (Now Live) TrumpRx.gov launched February 6, 2026, offering Zepbound at ~$346/month via a federal direct-to-consumer program
Potency testing ensures you're receiving the correct dose of medication - too little means the treatment may be ineffective, while too much could increase the risk of adverse effects